Eric Olson

Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA.

Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.

Pulmatrix Operating Co., Inc. develops pharmaceutical products for respiratory infectious diseases. Its iSPERSE powders can be used with an array of dry powder inhaler technologies and can be formulated with virtually any drug substance. The company was founded by David Alan Edwards, Mark J. Gabrielson, Alexander M. Klibanov and Robert S. Langer in 2003 and is headquartered in Lexington, MA.

Microbia, Inc. engages in the development of microbial manufacturing technologies for the production of chemicals from renewable raw materials. The company is headquartered in DE.

Euclises Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm develops a portfolio of COX-2 inhibitors optimized for cancer treatment based on its proprietary Euclicoxib platform and is in the process of selecting a lead clinical development candidate. The company was founded by John J. Talley in 2011 and is headquartered in St. Louis, MO.

SunEdison Semiconductor LLC develops, manufactures and sells silicon wafers to the semiconductor industry. The company is headquartered in Jefferson City, MO.

Kindex Pharmaceuticals, Inc. operates as a biopharmaceutical company. It focuses on discovering and developing of novel therapeutics for the treatment of metabolic. The company is headquartered in Boston, MA.

Sfara, Inc. engages in the development of mobile-based platforms. The company was founded by Sascha W. Simon and Robert A. Mazer on August 7, 2017 and is headquartered in Warwick, NY.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

Part of GlobalWafers Co., Ltd., MEMC Korea Co. is a leader in the manufacture and sale of wafers and related products to the semiconductor industry. The company is located in South Korea. The South Korean company has state-of-the-art manufacturing locations around the world. Founded in 1990, MEMC Korea offers leading-edge design and manufacturing of wafers.

Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY.

Part of Howard Hughes Medical Institute, Inc., The Janelia Farm Research Campus operates a research center. The company is based in Ashburn, VA.

Part of GlobalWafers Co., Ltd., MEMC Japan Ltd. is a Japanese company that manufactures semiconductor devices. The company is based in Utsunomiya City, Japan.

Drosmed LLC provides and develops drugs. It utilizes the fruit fly drosophila to take a whole animal approach to drug discovery for cancer metastasis and for diabetes-related diseases. The company was founded by Thomas John Baranski and Ross L. Cagan in 2006 and is headquartered in St. Louis, MO.

Science Exchange, Inc. operates an online marketplace for outsourcing science experiments. The firm is a community marketplace for scientists to list, discover access, and pay for scientific services from institutions around the world. The company was founded by Elizabeth Iorns, Ryan Abbott and Daniel John Knox in 2011 and is headquartered in San Francisco, CA.

Madauder Therapeutics, Inc. provides business services. The private company is based in Boston, MA.

Camp4 Therapeutics Corp. operates as a biotechnology company. The firm discovers a treatment option for patients. The company was founded by Paulina Hill and Leonard Zon on May 20, 2016 and is headquartered in Cambridge, the United Kingdom.

Andamijo LLC is a private investment fund. The private company is based in Chesterfield, MO. The CEO of the company is Shaker Sadasivam.

Auragent Bioscience LLC develops novel technologies for transforming bio detection. The private company is based in St. Louis, MO. The company was founded by Shaker Sadasivam. Shaker Sadasivam has been the CEO since incorporation.

DClimate, Inc. is a decentralized climate information and data infrastructure network that helps businesses, governments, and individuals to access and share institutional-grade climate data and risk models. The private company is based in Maryland Heights, MO. The company empowers participants to build climate solutions to power long-term resilience. DClimate indexes and organizes the earth's climate record on an immutable ledger, facilitating scalable and transparent climate tech development and access to critically important ecological data. The company was founded in 2016 by Robert Lattin, Bruce Hudson, Sesha Madireddi, and the CEO is Martin Duffy.

Nocion Therapeutics, Inc. is a biopharmaceutical company, which targets neurons mediating cough, itch, pain and inflammation without the addictive properties of opioids. The company was founded by Bruce Bean, Clifford Woolf and Bruce David Levy and is headquartered in Cambridge, MA.

Magnet Biomedicine, Inc. is a biotechnology company based in Cambridge, MA. Magnet Biomedicine is advancing molecular glue discovery with rational selection and design through their TrueGlue discovery platform. The company applies cutting-edge advancements in human biology and proteomics to identify fit-for-purpose glues that maximize therapeutic impact and offer prominent benefits such as improving selectivity, inducing biological synergy on defined targets, and addressing historically undruggable proteins. Magnet Biomedicine is revolutionizing human medicine with molecular glues and is tackling multiple disease areas and biological mechanisms, including cancer, cardiovascular disease, and immune disorders. The company was founded by Benjamin F. Cravatt, Stuart L. Schreiber, Michael Rosbash, Richa Saxena.

Belharra Therapeutics, Inc. is a drug discovery company that utilizes a unique photoaffinity-based chemoproteomics platform to identify novel small molecule drug candidates for previously difficult-to-treat diseases and conditions. The company is based in San Diego, CA, with its primary lab and offices located in the area. Belharra's proprietary discovery engine allows for the identification of small molecule starting points for drug development on any protein, in any conformational state, and in any cell type. The company was founded in 2021 by John Teijaro, Christopher G. Parker, Stuart L. Schreiber, and Benjamin F. Cravatt, and has since been led by CEO Jeffrey Jonker.